Towards Healthcare
Corticosteroids Market Size Envisioned at USD 6.91 Billion by 2033

Corticosteroids Market Size Envisioned at USD 6.91 Billion by 2033

Status: Published Category: Therapeutic Area Insight Code: 5111 Format: PDF / PPT / Excel

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Corticosteroids Market Assessment

  • Overview
  • Global Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Glucocorticoids
    • Mineralocorticoids
    • Synthetic Corticosteroids
  • Global Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Oral
    • Inhaled
    • Injectable
    • Ophthalmic
  • Global Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Rheumatology
    • Dermatology
    • Pulmonology
    • Gastroenterology
    • Neurology
    • Other Applications
  • Global Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Form (2021 – 2033)
    • Oral
    • Intravenous
    • Nasal
    • Topical
  • Global Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals and Clinics
    • Pharmacies and Retail
    • Specialty Clinics
    • Other End Users
  • Global Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa

North America Corticosteroids Market Assessment

  • Overview
  • North America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Glucocorticoids
    • Mineralocorticoids
    • Synthetic Corticosteroids
  • North America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Oral
    • Inhaled
    • Injectable
    • Ophthalmic
  • North America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Rheumatology
    • Dermatology
    • Pulmonology
    • Gastroenterology
    • Neurology
    • Other Applications
  • North America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Form (2021 – 2033)
    • Oral
    • Intravenous
    • Nasal
    • Topical
  • North America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals and Clinics
    • Pharmacies and Retail
    • Specialty Clinics
    • Other End Users

Europe Corticosteroids Market Assessment

  • Overview
  • Europe Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Glucocorticoids
    • Mineralocorticoids
    • Synthetic Corticosteroids
  • Europe Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Oral
    • Inhaled
    • Injectable
    • Ophthalmic
  • Europe Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Rheumatology
    • Dermatology
    • Pulmonology
    • Gastroenterology
    • Neurology
    • Other Applications
  • Europe Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Form (2021 – 2033)
    • Oral
    • Intravenous
    • Nasal
    • Topical
  • Europe Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals and Clinics
    • Pharmacies and Retail
    • Specialty Clinics
    • Other End Users

Asia Pacific Corticosteroids Market Assessment

  • Overview
  • Asia Pacific Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Glucocorticoids
    • Mineralocorticoids
    • Synthetic Corticosteroids
  • Asia Pacific Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Oral
    • Inhaled
    • Injectable
    • Ophthalmic
  • Asia Pacific Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Rheumatology
    • Dermatology
    • Pulmonology
    • Gastroenterology
    • Neurology
    • Other Applications
  • Asia Pacific Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Form (2021 – 2033)
    • Oral
    • Intravenous
    • Nasal
    • Topical
  • Asia Pacific Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals and Clinics
    • Pharmacies and Retail
    • Specialty Clinics
    • Other End Users

Latin America Corticosteroids Market Assessment

  • Overview
  • Latin America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Glucocorticoids
    • Mineralocorticoids
    • Synthetic Corticosteroids
  • Latin America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Oral
    • Inhaled
    • Injectable
    • Ophthalmic
  • Latin America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Rheumatology
    • Dermatology
    • Pulmonology
    • Gastroenterology
    • Neurology
    • Other Applications
  • Latin America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Form (2021 – 2033)
    • Oral
    • Intravenous
    • Nasal
    • Topical
  • Latin America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals and Clinics
    • Pharmacies and Retail
    • Specialty Clinics
    • Other End Users

Middle East and Africa Corticosteroids Market Assessment

  • Overview
  • Middle East and Africa Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Glucocorticoids
    • Mineralocorticoids
    • Synthetic Corticosteroids
  • Middle East and Africa Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Oral
    • Inhaled
    • Injectable
    • Ophthalmic
  • Middle East and Africa Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Rheumatology
    • Dermatology
    • Pulmonology
    • Gastroenterology
    • Neurology
    • Other Applications
  • Middle East and Africa Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Form (2021 – 2033)
    • Oral
    • Intravenous
    • Nasal
    • Topical
  • Middle East and Africa Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals and Clinics
    • Pharmacies and Retail
    • Specialty Clinics
    • Other End Users

Company Profiles

  • Pfizer
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Novartis
  • Merck & Co., Inc.
  • GlaxoSmithKline
  • AstraZeneca
  • Bausch Health Companies Inc.
  • Galderma
  • Cipla
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.

Conclusion & Recommendations

  • Insight Code: 5111
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: February 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

FAQ's

Corticosteroids, a class of steroid hormones, are extensively used in medicine for their potent anti-inflammatory and immunosuppressive properties. They treat autoimmune disorders, allergies, asthma, and inflammatory joint diseases like rheumatoid arthritis. Topical corticosteroids effectively address dermatological conditions such as eczema and psoriasis. Furthermore, corticosteroids prevent organ rejection post-transplantation and treat certain cancers and hematologic disorders. Their versatility in modulating the immune response and reducing inflammation makes them indispensable across diverse medical conditions.

Pulmonology emerges as the critical segment propelling the growth of the corticosteroid market. The demand for corticosteroids is notably heightened in pulmonology, driven by their practical use in managing respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other lung-related disorders.

A significant hurdle is the potential for side effects and safety concerns associated with prolonged or inappropriate corticosteroid use. These side effects may include bone loss, weight gain, immune system suppression, and metabolic disturbances.

Centers for Disease Control and Prevention, National Institute of Health, World Health Organization, HHS.gov., SEC.gov., Forum of International Respiratory Societies.

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 509

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 509